Up‐regulation of KISS1 as a novel target of Let‐7i in melanoma serves as a potential suppressor of migration and proliferation in vitro

Author:

Alkafaji Haider A.1,Raji Ahmed1,Rahman Heshu S.2,Zekiy Angelina O.3,Adili Ali4,Jalili Mohammadmahdi5,Hojjatipour Tahereh6,Cid‐Arregui Angel7,Shomali Navid58ORCID,Tarzi Saeed5,Tamjidifar Rozita5,Heshmati Ramin5,Marofi Faroogh8,Akbari Morteza5,Hasanzadeh Ali8,Deljavanghodrati Mina5ORCID,Jarahian Mostafa9,Sandoghchian Shotorbani Siamak58ORCID

Affiliation:

1. College of medicine University of Babylon Babylon Iraq

2. Department of Physiology College of Medicine University of Suleimanyah Suleimanyah Iraq

3. Sechenov First Moscow State Medical University Moscow Russian Federation

4. Department of Oncology Tabriz University of Medical Sciences Tabriz Iran

5. Immunology Research Center Tabriz University of Medical Sciences Tabriz Iran

6. Department of Hematology and Blood Transfusion Students Research Centre School of Allied Medicine Tehran University of Medical Sciences Tehran Iran

7. Targeted Tumor Vaccines Unit German Cancer Research Center (DKFZ) Heidelberg Germany

8. Department of Immunology Tabriz University of Medical Sciences Tabriz Iran

9. Toxicology and Chemotherapy Unit (G401) German Cancer Research Center Heidelberg Germany

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3